Skip to main content
. 2021 Jun 1;17(6):1183–1192. doi: 10.5664/jcsm.9162

Table 3.

Poisson regression estimates evaluating the association between nonadherence at 6 months and baseline characteristics (complete case analysis, n = 44).

Predictor Unadjusted Analysis Adjusted Analysisa Ridge Regressiona
RR 95% CI RR 95% CI RR
Demographics
 Age (y) 1.18 1.04–1.35 1.18 1.02–1.36 1.03
 Male sex 1.56 0.61–3.97 0.96 0.37–2.48 1.06
SDB diagnosis
 Hypoventilation/CSA (reference) 1.00 1.00 1.00
 Mixed diagnosis 0.91 0.51–1.60 0.53 0.13–2.28 1.05
 OSA 0.54 0.29–0.99 0.87 0.23–3.20 0.90
PAP mode
 CPAP (reference) 1.00 1.00 1.00
 BPAP 2.29 1.07–4.92 3.42 1.17–9.98 1.15
 Auto-PAP 1.50 0.60–3.74 2.34 0.79–6.98 0.99
Comorbidities
 Developmental delay 0.91 0.33–2.52 0.79 0.35–1.78 0.98
 Obesity 0.67 0.40–1.10 0.52 0.22–1.25 0.89
 Asthma 0.49 0.18–1.30 0.89 0.31–2.58 0.88
 Mental health disorder 1.27 0.67–2.41 1.10 0.38–3.18 1.03
 Behavioral disorder 1.06 0.52–2.14 0.91 0.47–1.73 0.99
PSG indices
 AHI (events/h) 1.00 0.99–1.01 1.00 0.99–1.01 1.00
 O2 saturation nadir (%) 1.04 1.00–1.08 1.05 1.00–1.10 1.01
 Maximum CO2 (mm Hg) 0.98 0.94–1.03 0.99 0.93–1.04 1.00
 Sleep efficiency (%) 0.98 0.97–1.00 1.00 0.98–1.02 1.00
 Arousal index (events/h) 0.99 0.95–1.03 0.97 0.94–1.02 1.00
Self-reported sleep symptoms
 Daytime somnolence (monthly or never) 0.79 0.41–1.54 0.86 0.25–2.92 0.96
 Daytime energy (good or excellent) 1.02 0.59–1.74 1.01 0.56–1.83 1.01
 Headache frequency (≥3 d/wk) 1.18 0.64–2.20 1.06 0.50–2.24 1.03

aThe reported relative risks in this column are adjusted for all other predictors described in this table. AHI = apnea-hypopnea index, auto-PAP = auto-titrating positive airway pressure, BPAP = bilevel positive airway pressure, CI = confidence interval, CPAP = continuous positive airway pressure, CSA = central sleep apnea, OSA = obstructive sleep apnea, PAP = positive airway pressure, PSG = polysomnography, RR = relative risk, SDB = sleep-disordered breathing.